Of the hundreds of millions of people living with diabetes, most liv. Dexcom wants to make sure they have tools to manage it.
An automated insulin delivery (AID) system boosted glycemic control in insulin-treated adults with type 2 diabetes using ...
Dexcom (Nadsaq:DXCM) announced today that it launched a new multi-region report evaluating type 2 diabetes treatments.
Jaeb Center for Health Research conducted a randomized controlled trial evaluating the impact of automated insulin delivery ...
Tandem Diabetes Care, Inc. announced NEJM publication of positive results from Control-IQ+ AID technology pivotal trial in ...
EDINBURGH, Scotland, and SAN DIEGO – Tech, not medicine, is the future of care for Type 2 diabetes patients, according to a new report from Dexcom.
A real-world analysis showed a link between continuous glucose monitor (CGM) distribution channel and outcomes for patients with diabetes.
First for Women on MSN5d
MDs Share 5 Things To Know About Blood Sugar Monitors—Even if You Don't Have DiabetesThe latest trend in health and fitness tracking may sound familiar: wearing continuous glucose monitors (CGMs). Many people ...
Medical device companies presented new data this week at the Advanced Technologies & Treatments for Diabetes conference.
Type 2 diabetes is a chronic condition affecting millions worldwide that often requires insulin therapy when blood sugar ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Over 13 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback